The aim of the present study was to assess the ability of a potentially probiotic strain to resist, in vitro, the effect of intestinal antimicrobial molecules. Methods and results: Strain CIDCA 133 of Lactobacillus delbrueckii subsp lactis was studied. Lactobacillus delbrueckii subsp bulgaricus as well as other gram positive and gram-negative bacteria were used for comparison purposes. The effect of different antimicrobial extracts was determined by diffusion assays, viable counts and growth kinetics. Human-defensins (h/(DI and h/>D2) were also included in the study. Two types of cellular fractions from Caco-2 cells were tested: (i) cytosolic fractions, obtained by sonication of cultured human enterocytes and (ii) cationic fraction, obtained by batch extraction of the cyto solic fraction with a weak cation exchange resin. In addition, the effect of Caco-2-secreted factors was studied. Strain CIDCA 133 was neither inhibited by Caco-2 secreted, cytosolic nor cationic fractions. Of note, human-defensins were inactive against strain CIDCA 133. In contrast, a related lactobacilli: Lactobacilli delbrueckii subsp bulgaricus (strain CIDCA 331) and other species of gram-positive or gram-negative bacteria were strongly inhibited. Conclusions: Strain CIDCA 133 is able to survive and grow in the presence of enterocyte-derived antimicrobial molecules. This ability is not a general property of lactobacilli. Significance and Impact of the Study: Results could provide a new insight into the mechanisms of the probiotic effect and encourage further studies on this field. Resistance to antimicrobial peptides can be relevant to understand the interaction of potentially probiotic strains with the host's immune system. This ability can be also relevant as a selection criterion for new probiotic strains.
Introduction
Probiotics are defined as 'live microbial food supplements that improve the health of the host' (Fuller 1989) . Fer mented dairy products containing probiotic bacteria are the most successful category of functional foods (Saxelin et al. 2005) . Lactobacilli and bifidobacteria are generally accepted as suitable candidates for the formulation of probiotics for humans. Consumption of probiotics positively affects the composition of intestinal microbiota and could provide several benefits for the host including the inhibition of intestinal pathogens, immunomodula tion, anticarcinogenic and antimutagenic activities, allevi ation of symptoms of lactose intolerance and reduction in serum cholesterol (Hord 2008) . Selection criteria of potentially probiotic strains include several recommenda tions as technological adaptability, accurate identification, GRAS status and capacity to survive, proliferate and develop their metabolic activity in vivo (Klaenhammer and Kullen 1999) . Also, acid-bile tolerance and adherence to epithelial cells are considered as relevant characteristics in a probiotic strain (Mishra and Prasad 2005) .
There are multiple factors that could affect the viability of probiotic micro-organisms in the gastrointestinal tract. The intestinal mucosa is protected from the attack of harmful enteric micro-organisms by host's defences in the context of both adaptive and innate immunity. Innate immunity, the first line of defence, uses nonclonal recog nition molecules and nonspecific effector molecules. Epithelial cells are the main players of innate immunity by providing a physical barrier against bacterial translo cation as well as by producing several biologically active molecules. These factors, along with the resident micro biota, control pathogenic micro-organisms (Ganz 2002) . The nonspecific effector molecules produced by the intes tinal epithelia include, mucins, enzymes, histones and antimicrobial peptides (AMPs) such as defensins (Hecht 1999) . These molecules could be either secreted to the extracellular milieu or remain in the cytoplasm and nuclei of the epithelial cells (Rose et al. 1998) . AMPs are rela tively small proteins (12-100 amino acids), positively charged, amphiphillic, and they have a broad antimicro bial spectrum (Jenssen et al. 2006) . Antimicrobial intesti nal peptides are produced by specialized cells (Paneth's cells) and also by epithelial cells (Liévin-Le Moal and Servin 2006) .
Human epithelial intestinal cells produce two types of AMPs: /J defensins (h/JD-1 and h/JD-2) and the cathelicidin hLL-37. At mucosal surfaces, AMPs can modify the balance of the colonizing microbiota (Salzman et al. 2007) .
The aim of the present study was to assess the in vitro effect on potentially probiotic lactobacilli of antimicrobial factors present in cultured human enterocytes.
Materials and methods

Bacterial strains and growth conditions
Shigella flexneri, Escherichia coli CM1, Bacillus cereus M2 and enteropathogenic Escherichia coli (EPEC) belong to the culture collection of the Cátedra de Microbiología of the Facultad de Ciencias Exactas (Universidad Nacional de La Plata, Argentine). Lactobacillus delbrueckii subsp. lactis strain CIDCA 133 and Lactobacillus delbrueckii subsp bulgaricus strain CIDCA 331 belong to the culture collection of the Centro de Investigación y Desarrollo en Criotecnología de Alimentos. (CIDCA, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, Argentine). Stock cultures were stored at -80°C, and micro-organisms were reactivated twice in liquid medium before the experiments. Gram-negative bacteria were grown in nutrient broth (Biokar Diagnostics, Beauvais, France) at 37°C for 16 h. Bacillus cereus was cultured in Brain Heart Infusion (BHI) broth (Biokar Diagnostics, Beauvais, France) containing 01% (w/v) glucose at 32°C under orbital agitation. Incubation was performed for 3 h to obtain bacteria in early stationary phase thus minimiz ing the ratio of sporulated B. cereus. Lactobacilli were grown in de Man, Rogosa, Sharp (MRS) broth (Biokar Diagnostics, Beauvais, France) in anaerobic conditions at 37°C for 16 h. Bacteria were harvested by centrifugation at 10 000 g for 10 min and suspended in phosphate buffered saline (PBS) or the appropriate growth medium.
Cell cultures
Caco-2 cells were cultured in 75-cm2 flasks (37°C, 5% CO2-95% air atmosphere) in Dulbecco's Modified Eagle's Medium (DMEM; Gibco BRL, Life Technologies, Rockville, MD, USA) supplemented with 10% (v/v) of foetal calf serum (PAA; Laboratories, GmbH, Pasching, Austria), 1% nonessential amino acids (Gibco, BRL, Life Technologies) and antibiotics (12 UI ml-1 penicillin and 12 ¿ig ml-1 streptomycin). Monolayers at postconfluence (15 days of incubation) were used throughout. Forty-four hours before the experiments, Caco-2 cells were incubated in DMEM medium without neither foetal calf serum nor antibiotics to avoid the presence of inhibitory compounds other than those produced by the epithelial cells.
Caco-2-secreted factors
After the incubation of cell monolayers with DMEM without foetal calf serum nor antibiotics, spent culture supernatant was collected, lyophilized and suspended in distilled water to obtain ten-fold concentrated extracts. Samples were stored at -20°C until use.
Caco-2 cytosolic and brush border extracts
Cytosolic fractions were obtained according to the protocol of Pinto et al. (1983) . Briefly, cells were collected and washed thrice using cold PBS. Then, they were suspended in Tris-Manitol buffer (2 mmol I-1 Tris, 50 mmol I-1 manitol, pH 71). Afterwards, cell suspensions were incubated on ice and sonicated thrice for 30 s in an Ultra sonic Desintegrator, (Model 60 w; MSE Ltd., USA) The lysate was incubated with CaCl2 (10 mmol I-1) for 10 min at 4°C and centrifuged at 950 g for 10 min. Resulting supernatant was centrifuged at 33 500 g for 30 min at 4°C. After this step, two fractions were obtained: supernatant (cytosolic fraction) and pellet (brush border fraction). Cytosolic fraction was concentrated (ten-fold) by lyophi lization as described earlier.
Batch extraction of the cationic fraction from cytosol
Batch extraction was used to concentrate the cationic fraction from cytosol (Porter et al. 1998 ). Cytosolic frac tion was incubated with a weak cation exchange resin (Macro-Prep CM; Bio-Rad Laboratories, CA, USA) at a ratio of 1 : 200 (resin : sample). After being incubated overnight at 4°C with gentle stirring, the resin was sepa rated by centrifugation (1500 g, 5 min). Afterwards, three washes with sodium phosphate buffer (10 mmol I-1) were performed. Adsorbed cations were eluted at 4°C by two steps of acid treatment i.e. 1 h in 10% (v/v) acetic acid and overnight in 5% (v/v) acetic acid. Supernatants collected from both extractions were pooled, concentrated by lyophilization and stored at -20°C until use.
Inhibition assays
Diffusion assays. Antimicrobial activity of Caco-2 extracts was determined by using a diffusion assay as described by Lehrer et u/. (1991) . Briefly, solid media were obtained by adding 1% (w/v) agarose to nutrient or MRS broth. Bacterial suspensions (1 X 108 CFU ml-1) were spread on the sur face of solid medium by using a cotton swab. Afterwards, 10 of samples was added to wells (2 5 mm in diameter) performed in the agarose. Plates were incubated for 24 h at 37°C, and zone diameters were measured.
Assays in liquid media.
To assess the effect of inhibitory factors on the growth kinetics of the strains under study, Caco-2 extracts or human /Ldefensins (h/iDI and h/?D2; Sigma-Aldrich Co., St Louis, MO, USA) were added to bacterial suspensions (1 X 105 CFU ml-1) in MRS or nutrient broth. /Ldefen sins were used at 0 5 qg ml-1. The number of surviving bacteria was determined by plating appropriate dilutions on either nutrient or MRS agar.
Statistical analysis
Results were compared by means of the two-tailed Student's f-test using InfoStat Software (Grupo InfoStat, FCA, Universidad Nacional de Córdoba, Argentina). or the brush border fraction with different bacteria revealed an inhibitory effect. The antagonism was observed both on gram-positive and gram-negative bacte ria ( Fig. 1) . Of note, whereas Shigella flexneri was strongly inhibited by both cytosolic and brush border fractions (zone diameters 14 5 ± 2 2 and 11 1 ± 14 mm, respec tively), enteropathogenic E. coli (EPEC) was only inhib ited by the cytosolic fraction (zone diameter 7 0 ± 1-4 mm). Interestingly, L. delbrueckii subsp lactis CIDCA 133 was not antagonized neither by the cytosolic nor the brush border extract from Caco-2 cells. In contrast, the related micro-organism Lactobacillus del brueckii subsp bulgaricus strain CIDCA 331 was strongly inhibited by the cytosolic fraction. In addition, ten-fold concentrated spent culture supernatants from Caco-2 cells were assayed. Even though inhibition zones of 13 ± 1 mm and 14 ± 1 mm were observed for strains 331 and CM1, respectively, no inhibition on strain 133 was detected (zone diameter 2 5 ± 0 0 mm).
It is worth noting that assays performed by using agar, instead of agarose, as the solidifying agent led to smaller zone diameters (data not shown).
Results
Effect of Caco-2 extracts on micro-organisms
To investigate the effect on different micro-organisms of cellular fractions obtained from Caco-2 cells, diffusion assays were conducted in culture media solidified with agarose. Incubation of either the Caco-2 cytosolic fraction
Characterization of the inhibitory activity
To distinguish between bacteriostatic and bactericidal activities, we performed assays in liquid medium. As shown in Fig. 2 , incubation of E. coli CM1 with cytosolic fraction from Caco-2 cells led to a 3-log reduction in bacterial viability after 3-h incubation. This bactericidal effect was also observed for strain 331. Indeed, after 3-h Results are scored according to the size of zone diameter in the diffu sion assay. (+) 5-10 mm of inhibition zone; (++) 11-20 mm; (-) indicates no inhibitory effect (2-5 mm corresponding to the diameter of the well).
incubation with cytosolic extracts, viable counts of strain 331 decreased from 104 CFU ml-1 to 103 CFU ml-1. The findings that zone diameters in diffusion assays performed with agarose were larger than those obtained in agar-containing media, prompted us to investigate the role of cationic compounds in the inhibitory effect. To this end, we performed batch extraction of the cytosolic fraction from Caco-2 cells with a weak cation exchange resin. As given in Table 1 , cationic fractions from Caco-2 cells showed similar inhibition pattern that cytosolic extracts.
Effect of human /1-defensins
Even though several positively charged molecules (e.g. hi stones, phospholipase A2, defensins) could be present in the cationic extracts, the fact that human beta-defensins (h/iDs) are the most abundant antimicrobial peptides in epithelial cells (Yanagi et al. 2007 ), prompted us to study the effect of purified human defensins.
Growth kinetics of lactobacilli performed in the pres ence of human /J-defensins (h/JDj and h/JD2) showed that whereas Lactobacillus delbrueckii subsp bulgaricus CIDCA 331 was inhibited by both defensins (mainly by h/JD2), growth kinetics of Lactobacillus delbrueckii subsp lactis CIDCA 133 was not modified by defensins (Fig. 3) . No effects were observed on the growth of E. coli CM1 in the presence of human defensins (data not shown).
Discussion
Survival of probiotic micro-organisms in the gastrointesti nal tract depends on the ability to cope with several antimicrobial molecules produced by different cell popu lations.
Caco-2 cells constitute a widely accepted model for the study of the interaction between micro-organisms and cell populations relevant to the defence mechanisms of the intestinal tract. It is known that Caco-2 cells are able to produce a set of molecules with antibacterial activity e. g. lysozyme, defensins, phospholipases and a-antitrypsin (Bernet-Camard et al. 1996; Ganz 2002) . In the present study, we used Caco-2-derived extracts to assess the effect of such inhibitory molecules on intestinal bacteria.
Whereas cytosolic extracts were inhibitory to most of the strains under study, strains CIDCA 133 and enteropathogenic E. coli (EPEC) showed a different behaviour, i.e. strain 133 was not inhibited, and EPEC was inhibited but in a lesser extent than other strains. This behaviour could be expected for a pathogenic micro-organism (EPEC), but, surprisingly, a nonpathogenic and poten tially probiotic micro-organism such as strain CIDCA 133 was also able to resist the inhibitory effect of Caco-2derived factors. Furthermore, a different Lactobacillus strain was strongly inhibited by cytosolic extracts (Fig. 1) . Noteworthy, concentrated spent supernatants from Caco-2 cell cultures inhibited both E. coli CM1 and L. delbreuckii subsp bulgaricus CIDCA 331, thus indicating that, in contrast to strain 133, these strains would not be active in the presence of secreted factors from enterocytes.
Defensins as well as other cationic molecules with anti bacterial activity are important effectors of the innate immune system. Strain CIDCA 133 was resistant not only to the effect of the Caco-2 cationic extract but also to purified human /i defensins (Table 1, Fig. 3) .
The observed effect depends on the defensin/bacteria ratio. Indeed, when 103 CFU ml-1 was incubated for 24 h with different concentrations of human /J-defensins, we found that strains CM1 and 133 were able to grow in the presence of 5 and 2 5 pg ml-1 of human betadefensins, respectively, whereas strain 331 is able to grow at the concentrations of 0 08 pg ml-1 hBD (data not shown). It is worth noting that concentration of h/JD2 in human faeces ranges from 0 01 to 0 06 pg ml-1 (Mondel et al. 2009 ).
Antimicrobial peptides (AMPs) lead to antimicrobial effect by damaging or destabilizing cytoplasmic mem brane or acting at cytoplasmic level by inhibiting essential cellular process such as protein or nucleic acid synthesis (Brogden 2005) . Regardless of their precise mode of action, the activities of AMPs are almost universally dependent upon interaction with the bacterial cell mem brane (Hancock and Rozek 2002) . Interactions between antimicrobial peptides and bacteria are determined by electrostatic attraction between the positive-charged AMPs and anionic bacterial structures such as lipids and other surface structures (Jenssen et al. 2006) .
Bacterial pathogens have evolved mechanisms to limit the effectiveness of AMPs. These mechanisms involve the diminution of the electrostatic interaction between AMPs and bacterial surface by reducing the net negative charge of the bacterial cell envelope through the covalent modifi cation of anionic molecules such as lipid A, teichoic acids or phospholipids (Peschel 2002) .
As strain CIDCA 133 was affected neither by the cat ionic extract from Caco-2 cells nor by purified human /J defensins, whereas strain CIDCA 331 was strongly inhib ited, we could hypothesize that these strains differ in the composition of lipids or teichoic acids. In fact, chromato graphic analysis revealed the different proportions of fatty acids present in cellular lipids between the two strains (Gomez Zavaglia et al. 2000) .
The ability of probiotic micro-organisms to induce the production of antimicrobial molecules has been reported. Indeed, probiotic bacteria provoked a strong induction of h/JD2 synthesis in intestinal epithelial cells Caco-2 (Schlee et al. 2007 (Schlee et al. , 2008 . Furthermore, in vivo studies demon strated that oral administration of potentially probiotic E. coli strains increases faecal secretion of h/JD2 in healthy volunteers (Mondel et al. 2009 ). It is worth noting that this probiotic strain was not resistant to the induced anti microbial factors such as h/JD2. These findings could indicate the possibility of a suicidal character of this interaction (Mondel et al. 2009 ).
Lactobacillus delbrueckii subsp lactis CIDCA 133 dem onstrated the ability to antagonize biological effect of enterohaemorrhagic E. coli (EHEC) in vitro and to inhibit nitrate reductase activity of a nonpathogenic commensal E. coli strain (Hugo et al. 2006 (Hugo et al. , 2008 . In the present study, we showed the ability of this strain to resist the effects of antimicrobial factors derived from cultured human enterocytes as well as to overcome the inhibitory effect of human /J defensins. These findings could be relevant to predict the competitiveness of this strain in vivo and to understand the interaction of selected probiotic micro-organisms with host's cells and the resulting immune response.
